Trial Details

COMPLETED
Basic Information
Clinical ID c1799
Identifier NCT05033431
Trial Title Study to Evaluate the Pharmacokinetics (Movement of Drugs Within the Body), Safety and Tolerability of Brazikumab in Healthy Chinese and White Participants
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Healthy Participants
Interventions DRUG: Brazikumab
Participant Information
Sponsor AstraZeneca
City Glendale
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2021-10-11
Primary Completion Date 2022-10-12
Completion Date 2022-10-12